MERCKLE GMBH — Celecoxib Importer Profile
Pharmaceutical Importer · #9 buyer for Celecoxib · $2.0M import value · 48 shipments · GERMANY · DGFT Verified
MERCKLE GMBH is the #9 importer of Celecoxib from India with $2.0M in import value and 48 verified shipments. MERCKLE GMBH holds a 1.3% market share in Celecoxib imports based in GERMANY. The company sources from 2 verified suppliers across 24 formulations shipped to 1 country. Overall, MERCKLE GMBH imports 3 pharmaceutical products worth $3.0M across 3 therapeutic categories.
MERCKLE GMBH — Celecoxib Import Profile: Suppliers, Formulations & Sources

Who Actually Supplies Celecoxib to MERCKLE GMBH?
Verified from 48 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| TEVAPHARM INDIA PRIVATE LIMITED | $1.6M | 39 | 79.9% |
| MARKSANS PHARMA LIMITED | $401.6K | 9 | 20.1% |
MERCKLE GMBH sources Celecoxib from 2 verified Indian suppliers based on 48 customs records. The primary supplier is TEVAPHARM INDIA PRIVATE LIMITED accounting for 79.9% of imports.
How Does MERCKLE GMBH Compare to Nearest Celecoxib Importers?
Buyers ranked immediately above and below #9 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | LIFESCIENCE LOGISTICS | UNITED STATES | $3.0M | 59 | $50.0K |
| 7 | J KNIPPER COMPANY | UNITED STATES | $2.6M | 85 | $30.0K |
| 9 | MERCKLE GMBH ★ | GERMANY | $1.7M | 41 | $42.5K |
| 11 | E.P.DIS | FRANCE | $1.6M | 36 | $44.2K |
| 12 | APOTEX INC, | CANADA | $1.5M | 36 | $42.3K |
MERCKLE GMBH ranks #9 among 781 Celecoxib importers from India. Average shipment value of $42.5K compared to the market average of $44.8K. The closest competitors by value are LIFESCIENCE LOGISTICS and J KNIPPER COMPANY.
Where Does MERCKLE GMBH Import Celecoxib To?
Destination countries from 48 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| GERMANY | $2.0M | 48 | 100.0% |
MERCKLE GMBH imports Celecoxib to 1 country. The primary destination is GERMANY receiving 100.0% of shipments worth $2.0M.
What Celecoxib Formulations Does MERCKLE GMBH Import?
| Formulation | Value | Shipments |
|---|---|---|
| 240252, CELECOXIB 200MG HK, BATCH 122033 | $318.2K | 8 |
| 240252, CELECOXIB 200MG HK, BATCH 122021 | $279.5K | 6 |
| 240252, CELECOXIB 200MG HK, BATCH 122019 | $271.2K | 6 |
| 240252, CELECOXIB 200MG HK, BATCH 122023 | $203.6K | 5 |
| PHARMACEUTICAL PRODUCTS : CELECOXIB 200MG HK H, ( BATCH NO: 230457,230458,230459,230523,230524 MFG DT: NOV-2023 EXP DT:NOS | $144.7K | 3 |
| 240252, CELECOXIB 200MG HK, BATCH 122022 | $89.6K | 2 |
| PHARMACEUTICAL PRODUCTS : CELECOXIB 200M | $50.0K | 1 |
| PHARMACEUTICAL ARTICLE / ODS / PRODUCT / ITEM : CELECOXIB 200MG HK H, Batch No: 230368, 230369 Mfg Dt: SEP-2023 Exp Dt: AUG-2026 Batch no | $50.0K | 1 |
| PHARMACEUTICAL PRODUCTS : CELECOXIB 200MG HK H, BATCH NO: 240181,240182,240198,240199, (MFG DT: APR-2024 EXP DT: MAR-202 | $50.0K | 1 |
| 240252 CELECOXIB 200MG HK H, BATCH 1220 | $47.6K | 1 |
MERCKLE GMBH imports 24 distinct Celecoxib formulations from India. The top formulation is 240252, CELECOXIB 200MG HK, BATCH 122033 with 8 shipments worth $318.2K.
Regulatory Requirements: Importing Celecoxib into Germany
What MERCKLE GMBH and other importers must comply with to import Celecoxib from India
Regulatory Authority
Federal Institute for Drugs and Medical Devices (BfArM) / European Medicines Agency (EMA) (BfArM/EMA)
Approval Process for Generic Celecoxib
Marketing Authorisation Application (MAA) under EU Directive 2001/83/EC. Decentralized or Mutual Recognition Procedure for generics. Requires CTD Module 1–5 dossier.
Typical timeline: 12–18 months via Decentralized Procedure
GMP Requirements
EU GMP (EudraLex Vol. 4) compliance; GMP certificate issued by competent authority; WHO Prequalification accepted as supporting evidence
Import Licence & Documentation
Wholesale Distribution Authorisation (WDA) and Manufacturing/Import Authorisation (MIA) required for importer. Qualified Person (QP) must certify each batch.
Labeling & Packaging
EU labeling per Directive 2001/83/EC; German language patient leaflet (PIL) mandatory; serialization under EU Falsified Medicines Directive (FMD)
Note: EU FMD serialization and tamper-evident packaging mandatory since February 2019. Indian API/FDF manufacturers must hold EU GMP certificate.
Regulatory information is provided for general reference based on publicly available BfArM/EMA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with BfArM/EMA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Celecoxib from India and How Much Does MERCKLE GMBH Import?
India exported $35.0M worth of Celecoxib through 4,880 shipments from 326 suppliers to 112 countries, serving 781 buyers globally. MERCKLE GMBH imports $2.0M of this total, accounting for 1.3% of India's Celecoxib exports with 48 shipments from GERMANY. This is verified from 48 customs shipment records covering 24 distinct formulations.
What Is the Average Order Value for MERCKLE GMBH's Celecoxib Imports?
MERCKLE GMBH's average Celecoxib order value is $41.6K per consignment, based on 48 shipments totaling $2.0M. MERCKLE GMBH is based in GERMANY and ranks #9 among all Celecoxib importers from India by value. The company sources from 2 verified suppliers in India.
Who Supplies Celecoxib to MERCKLE GMBH?
MERCKLE GMBH sources Celecoxib from 2 verified Indian suppliers: TEVAPHARM INDIA PRIVATE LIMITED ($1.6M, 79.9%), MARKSANS PHARMA LIMITED ($401.6K, 20.1%). This is based on 48 customs records.
How Does MERCKLE GMBH Compare to Other Celecoxib Importers?
MERCKLE GMBH ranks #9 among 781 Celecoxib importers from India with a 1.3% market share. The top 3 importers are CIPLA USA INC UPS SUPPLY CHAIN SOLU ($5.7M), J. KNIPPER & COMPANY ($4.3M), NORTHSTAR DISTRIBUTION CENTER 8912 ($3.5M). MERCKLE GMBH processed 48 shipments from GERMANY.
About MERCKLE GMBH
MERCKLE GMBH imports 3 products worth $3.0M. Beyond Celecoxib, top products include Cefpodoxime, Clonazepam. View the complete MERCKLE GMBH profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Celecoxib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Celecoxib shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: MERCKLE GMBH matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as MERCKLE GMBH's capped import value divided by total capped export value for Celecoxib across all Indian exporters.
- 5.Verified Records: This page is backed by 48 individual customs records matching MERCKLE GMBH importing Celecoxib, covering 24 formulations from 2 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 112+ countries, 781+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Celecoxib Import Data for MERCKLE GMBH
Access order-level details, pricing data, supplier connections, and competitive analysis for MERCKLE GMBH's Celecoxib imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
MERCKLE GMBH
Full Company Profile →
3 products · $3.0M total trade · 3 categories
MERCKLE GMBH × Celecoxib
Verified from customs records
Company Overview
Top Products by MERCKLE GMBH
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for MERCKLE GMBH.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Celecoxib. For current order-level data, contact TransData Nexus.